188 related articles for article (PubMed ID: 35799022)
1. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
2. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
4. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.
Wang X; Yu Q; Bai X; Li X; Sun Y; Peng X; Zhao R
Eur J Cancer Prev; 2024 May; 33(3):271-281. PubMed ID: 37942897
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
[TBL] [Abstract][Full Text] [Related]
6. Involvement of microglial P2X7 receptor in pain modulation.
Zhang J; Gao L; Zhang Y; Wang H; Sun S; Wu LA
CNS Neurosci Ther; 2024 Jan; 30(1):e14496. PubMed ID: 37950524
[TBL] [Abstract][Full Text] [Related]
7. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.
Burnstock G; Knight GE
Purinergic Signal; 2018 Mar; 14(1):1-18. PubMed ID: 29164451
[TBL] [Abstract][Full Text] [Related]
8. P2X7 Receptor: an Emerging Target in Alzheimer's Disease.
Huang Q; Ying J; Yu W; Dong Y; Xiong H; Zhang Y; Liu J; Wang X; Hua F
Mol Neurobiol; 2024 May; 61(5):2866-2880. PubMed ID: 37940779
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of natural product-derived compounds acting on P2X7R: The promising therapeutic drugs in disorders.
Liu Z; Liu W; Han M; Wang M; Li Y; Yao Y; Duan Y
Phytomedicine; 2024 Jun; 128():155334. PubMed ID: 38554573
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor: a potential target for treating comorbid anxiety and depression.
Liu J; Liu TT; Mou L; Zhang Y; Chen X; Wang Q; Deng BL; Liu J
Purinergic Signal; 2024 Apr; ():. PubMed ID: 38642324
[TBL] [Abstract][Full Text] [Related]
11. The P2X7 Receptor in Autoimmunity.
Grassi F; Salina G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762419
[TBL] [Abstract][Full Text] [Related]
12. Commentary: P2X7 receptor modulation is a viable therapeutic target for neurogenic pain with concurrent sleep disorders.
Shah S; Kondapalli K; Rasheed N; Chu XP
Front Neurosci; 2023; 17():1293174. PubMed ID: 38099200
[No Abstract] [Full Text] [Related]
13. Progress in the relationship between P2X7R and colorectal cancer.
Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
[TBL] [Abstract][Full Text] [Related]
14. P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
Ledderose S; Rodler S; Eismann L; Ledderose G; Rudelius M; Junger WG; Ledderose C
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190249
[TBL] [Abstract][Full Text] [Related]
15. Purinergic P2X7R as a potential target for pancreatic cancer.
Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X
Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling: Diverse effects and therapeutic potential in cancer.
Kaur J; Dora S
Front Oncol; 2023; 13():1058371. PubMed ID: 36741002
[TBL] [Abstract][Full Text] [Related]
17. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract][Full Text] [Related]
18. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
19. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
